|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients显示文摘 | Heinz Ludwig Simon Van Belle Peter Barrett-Lee Gunnar Birgeg?rd Carsten Bokemeyer Pere Gascón Paris Kosmidis Maciej Krzakowski Johan Nortier Patrizia Olmi Maurice Schneider Dirk Schrijvers | 2004 | European Journal of Cancer2004，，15： | 2 |
| 2 | Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer显示文摘 | David R. Spigel Thomas J. Ervin Rodryg A. Ramlau Davey B. Daniel Jerome H. Goldschmidt George R. Blumenschein Maciej J. Krzakowski Gilles Robinet Benoit Godbert Fabrice Barlesi Ramaswamy Govindan Taral Patel Sergey V. Orlov Michael S. Wertheim Wei Yu Jipi | 2013 | Journal of Clinical Oncology2013，，32： | 1 |
| 3 | Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase Ⅱ study显示文摘 | Chua D Krzakowski M Chouaid C | 2010 | Clin Lung Cancer2010，11，3： | 1 |
| 4 | Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial显示文摘 | Martin Reck Rolf Kaiser Anders Mellemgaard Jean-Yves Douillard Sergey Orlov Maciej Krzakowski Joachim von Pawel Maya Gottfried Igor Bondarenko Meilin Liao Claudia-Nanette Gann José Barrueco Birgit Gaschler-Markefski Silvia Novello | 2014 | Lancet Oncology2014，，2： | 1 |
| 5 | Phase Ⅲ study comparing oral topotecan to intravenous docetaxel in patients with pretreated advanced non-small-cell lung cancer 显示文摘 | Ramlau R Gervais R Krzakowski M | 2006 | J Clin Oncol2006，24，18： | 1 |
| 6 | Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non- small-cell lung cancer: a phase 11/ trial显示文摘 | Scagliotti G V Krzakowski M Szczesna A | 2012 | J Clin Oncol2012，30，17： | 1 |
| 7 | Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase Ⅲ trial显示文摘 | Brodowicz T Krzakowski M Zwitter M | 2006 | Lung Cancer2006，52，2： | 1 |
| 8 | A Phase Ⅱ study of gemcitabine plus cisplatin in patients with advanced non-samall cell lung cancer:clinical outcomes and quality of life显示文摘 | Jassem J Krzakowski M Roszkowski K | 2002 | Lung Cancer2002，35，： | 1 |
| 9 | A multicenter,randomized, Phase Ⅲ study of docetaxel plus best supportive care versus best supportive care in chemotherapy- naive patients with metastatic or nonresectable localized non - small cell lung cancer ( NSCLC ) 显示文摘 | Roszkowski K Pluzanska A Krzakowski M | 2000 | Lung Cancer2000，27，： | 1 |
| 10 | Phase III trim comparing vinflunine with docetaxet in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy 显示文摘 | Krzakowski M Ramlau R Jassem J | 2010 | J Clin Oncol2010，28，13： | 1 |
| 11 | Anemia profiles in patients with lung cancer, what have we learned from the European Cancer Anemia Survey(ECAS) 显示文摘 | Kosmidis P Krzakowski M | 2005 | Cancer2005，50，3： | 1 |
| 12 | New agents within the preoperative chemotherapy of non-small call lung cancer显示文摘 | Krzakowski M | 2001 | Lung Cancer2001，34，2： | 1 |
| 13 | Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non-small cell lung carcinoma and other solid tumors: a randomized,PhaseⅢ ,double blind,placebo-controlled trial显示文摘 | Rosen L S Gordon D Tehekmedyian N S Yanagihara R Hirsh V Krzakowski M | 2004 | Cancer2004，100，： | 1 |
| 14 | Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer:A phase Ⅲ trial显示文摘 | Brodowicz T Krzakowski M Zwitter M | | 0，，02： | 1 |
| 15 | Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer:a phaseⅢtrial显示文摘 | Brodowicz T Krzakowski M Zwitter M | | 0，，： | 1 |
| 16 | Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer:a phaseⅢtrial显示文摘 | Brodowicz T Krzakowski M Zwitter M | 2006 | Lung Cancer2006，52，2： | 1 |
| 17 | A phase Ⅱ study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life 显示文摘 | JassemJ Krzakowski M Roszkowki K | 2002 | Lung Cancer2002，35，1： | 1 |
| 18 | Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase Ⅲ trial显示文摘 | Scagliotti GV Krzakowski M Szczesna A | 2012 | J Clin Oncol2012，30，17： | 1 |
| 19 | Anemia profiles in patients with lungcancer: what have we learned from the European Cancer A- naemia Survey (ECAS) 显示文摘 | Kosmidis P Krzakowski M | 2005 | Lung Cancer2005，50，3： | 1 |
| 20 | Cis- platin and gemcitabine first-line chemotherapy fol- lowed by maintenance gemcitabine or best sup- portive care in advanced non-small cell lung cancer: a phase Ⅲ trial显示文摘 | Brodowicz T Krzakowski M Zwitter M | 2006 | Lung Cancer2006，52，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员